Condition

Essential Thrombocythaemia clinical trials and research

• 2Clinical trials
• 3Countries

All recruiting trials (2)

• MPNdpoint: Long-term Look at Philadelphia-negative Myeloproliferative Neoplasms

  This study tests how outcomes differ for patients 16 and older with polycythemia vera, essential thrombocythemia, or myelofibrosis by collecting and analyzing clinical and treatment data.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan · NCT07863466

• STP938 as a single daily oral treatment for adults with high‑risk essential thrombocythaemia

  This study will try daily oral STP938 in adults with high‑risk essential thrombocythaemia who are resistant to or intolerant of hydroxycarbamide to see if it safely lowers platelet counts.

  Recruiting at 13 sites Phase 2 Step Pharma, SAS · Poitiers, New Aquitaine and 13 other locations · NCT06786234

Related topics

Quick answers

How many Essential Thrombocythaemia clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Italy (1 trial), France (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →